Scholar Rock to Present at the 37th Annual J.P. Morgan Healthcare Conference
A live webcast of the presentation may be accessed by visiting the Investors & Media section of the
About Scholar Rock
Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Scholar Rock is creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of serious diseases, including neuromuscular disorders, cancer, fibrosis and anemia. Scholar Rock’s newly elucidated understanding of the molecular mechanisms of growth factor activation enabled it to develop a proprietary platform for the discovery and development of monoclonal antibodies that locally and selectively target these signaling proteins at the cellular level. By developing product candidates that act in the disease microenvironment, the Company intends to avoid the historical challenges associated with inhibiting growth factors for therapeutic effect.
Scholar Rock® is a registered trademark of
Scholar Rock Contact: Investors/Media
Catherine Huchu@scholarrock.com 917-601-1649 Media Contact: The Yates Network Kathryn Morriskathryn@theyatesnetwork.com 914-204-6412
Source: Scholar Rock